fluconazole has been researched along with Complications, Infectious Pregnancy in 43 studies
Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.
| Excerpt | Relevance | Reference |
|---|---|---|
| "While topical azoles are the first-line treatment for fungal infections, oral fluconazole is frequently used during pregnancy." | 7.91 | Associations between low- and high-dose oral fluconazole and pregnancy outcomes: 3 nested case-control studies. ( Abrahamowicz, M; Bérard, A; Bernatsky, S; de Moura, CS; Gorgui, J; Sheehy, O; Zhao, JP, 2019) |
| "To study the association between oral fluconazole exposure during pregnancy and the risk of spontaneous abortion and stillbirth." | 7.83 | Association Between Use of Oral Fluconazole During Pregnancy and Risk of Spontaneous Abortion and Stillbirth. ( Hviid, A; Melbye, M; Mølgaard-Nielsen, D; Pasternak, B; Svanström, H, 2016) |
| " She took a 150-mg dose of fluconazole 2 weeks ago for the treatment of vaginal candidiasis and she is worried about the effect on her child and pregnancy." | 7.81 | Fluconazole exposure during pregnancy. ( Bozzo, P; Kaplan, YC; Koren, G, 2015) |
| "Recurrence is also more common in pregnant women, and therapeutic responses are reduced." | 5.38 | Yeast vaginitis during pregnancy: susceptibility testing of 13 antifungal drugs and boric acid and the detection of four virulence factors. ( Aydin, M; Güzel, AB; Ilkit, M; Kalkanci, A; Khalil, II; Kuştimur, S, 2012) |
| "A prescription-event monitoring (PEM) study has confirmed that fluconazole, a bis-triazole oral antifungal drug, is a safe and effective treatment for vaginal candidiasis." | 5.29 | Safety of fluconazole in the treatment of vaginal candidiasis. A prescription-event monitoring study, with special reference to the outcome of pregnancy. ( Inman, W; Pearce, G; Wilton, L, 1994) |
| " Five were exposed to 200-800 mg fluconazole during pregnancy." | 5.05 | Cryptococcosis in pregnancy and the postpartum period: Case series and systematic review with recommendations for management. ( Boulware, DR; Evans, EE; Meya, DB; Muzoora, C; Nalintya, E; Ndyetukira, JF; Nuwagira, E; Pastick, KA; Rajasingham, R; Rhein, J; Skipper, C; Ssebambulidde, K; Stephens, N; Tugume, L, 2020) |
| "To examine the risk of congenital malformations associated with exposure to oral fluconazole at commonly used doses in the first trimester of pregnancy for the treatment of vulvovaginal candidiasis." | 3.96 | Oral fluconazole use in the first trimester and risk of congenital malformations: population based cohort study. ( Bateman, BT; Gray, KJ; Hernandez-Diaz, S; Huybrechts, KF; Mogun, H; Straub, L; Zhu, Y, 2020) |
| "While topical azoles are the first-line treatment for fungal infections, oral fluconazole is frequently used during pregnancy." | 3.91 | Associations between low- and high-dose oral fluconazole and pregnancy outcomes: 3 nested case-control studies. ( Abrahamowicz, M; Bérard, A; Bernatsky, S; de Moura, CS; Gorgui, J; Sheehy, O; Zhao, JP, 2019) |
| "Low-dose fluconazole is used commonly to treat vulvovaginal candidiasis, a condition occurring frequently during pregnancy." | 3.83 | Fluconazole use and birth defects in the National Birth Defects Prevention Study. ( Browne, ML; Carter, TC; Cunniff, CM; Druschel, CM; Howley, MM; Romitti, PA, 2016) |
| "To study the association between oral fluconazole exposure during pregnancy and the risk of spontaneous abortion and stillbirth." | 3.83 | Association Between Use of Oral Fluconazole During Pregnancy and Risk of Spontaneous Abortion and Stillbirth. ( Hviid, A; Melbye, M; Mølgaard-Nielsen, D; Pasternak, B; Svanström, H, 2016) |
| " She took a 150-mg dose of fluconazole 2 weeks ago for the treatment of vaginal candidiasis and she is worried about the effect on her child and pregnancy." | 3.81 | Fluconazole exposure during pregnancy. ( Bozzo, P; Kaplan, YC; Koren, G, 2015) |
| "Fluconazole is widely used for the treatment of candidiasis." | 3.74 | Maternal use of fluconazole and risk of congenital malformations: a Danish population-based cohort study. ( Erichsen, R; Gislum, M; Nørgaard, M; Pedersen, L; Schønheyder, HC; Søgaard, KK; Sørensen, HT, 2008) |
| " Advances in pharmacokinetics (PK) and pharmacodynamics (PD) of antimicrobial medications have led to improved dosing guidance for neonates." | 2.52 | New antifungal and antiviral dosing. ( Monk, HM; Wade, KC, 2015) |
| "Fluconazole (FLCZ) is an azole antifungal agent and it has shown excellent clinical activities in suppressing fungemia with Candida albicans after hematopoietic stem cell transplantation." | 1.48 | Breakthrough Candida guilliermondii (Meyerozyma guilliermondii) fungemia after cord blood transplantation for extranodal NK-cell lymphoma with azole prophylaxis. ( Ishida, F; Ito, T; Kikuchi, K; Nakazawa, H; Nishina, S; Sakai, H; Senoo, Y, 2018) |
| "Intra-amniotic Candida infection is associated with preterm rupture of membranes, preterm labor, severe neonatal infection, and fetal death." | 1.39 | Intra-amniotic fluconazole therapy for Candida albicans intra-amniotic infection. ( Bean, LM; Beiswenger, TR; Dobak, WJ; Jackson, JR; Thorp, JA, 2013) |
| "Recurrence is also more common in pregnant women, and therapeutic responses are reduced." | 1.38 | Yeast vaginitis during pregnancy: susceptibility testing of 13 antifungal drugs and boric acid and the detection of four virulence factors. ( Aydin, M; Güzel, AB; Ilkit, M; Kalkanci, A; Khalil, II; Kuştimur, S, 2012) |
| "The patient with cryptococcal meningitis was treated with amphotericin B and fluconazole and the patient with cerebral aspergilloma with voriconazole." | 1.38 | Two rare cases of central nervous system opportunistic mycoses. ( Baršić, B; Mlinarić Missoni, E, 2012) |
| "Fenticonazole was assessed by European Committee on Antimicrobial Susceptibility Testing and CLSI microdilution methods for the first time, and the results showed excellent agreement (97%) and significant interclass correlation coefficient (P < 0." | 1.35 | Fenticonazole activity measured by the methods of the European Committee on Antimicrobial Susceptibility Testing and CLSI against 260 Candida vulvovaginitis isolates from two European regions and annotations on the prevalent genotypes. ( Alexopoulos, EC; Antonopoulou, S; Aoun, M; Baka, S; Grigoriou, O; Kalambokas, T; Kouskouni, E; Logothetis, E; Papadias, K; Velegraki, A; Zannos, A, 2009) |
| "Fluconazole is a triazole antifungal used to treat mycotic infections." | 1.33 | Prenatal exposure to fluconazole: an identifiable dysmorphic phenotype. ( Lopez-Rangel, E; Van Allen, MI, 2005) |
| "A prescription-event monitoring (PEM) study has confirmed that fluconazole, a bis-triazole oral antifungal drug, is a safe and effective treatment for vaginal candidiasis." | 1.29 | Safety of fluconazole in the treatment of vaginal candidiasis. A prescription-event monitoring study, with special reference to the outcome of pregnancy. ( Inman, W; Pearce, G; Wilton, L, 1994) |
| "Fluconazole has been associated with various teratisms in animals, including craniofacial ossification defects, thin, wavy ribs, and renal pelvis defects." | 1.29 | Fluconazole-induced congenital anomalies in three infants. ( Abraham, J; Andersen, HF; Bartley, JA; Blomquist, IK; Pursley, TJ, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 9 (20.93) | 18.2507 |
| 2000's | 11 (25.58) | 29.6817 |
| 2010's | 20 (46.51) | 24.3611 |
| 2020's | 3 (6.98) | 2.80 |
| Authors | Studies |
|---|---|
| Antonopoulou, S | 1 |
| Aoun, M | 1 |
| Alexopoulos, EC | 1 |
| Baka, S | 1 |
| Logothetis, E | 1 |
| Kalambokas, T | 1 |
| Zannos, A | 1 |
| Papadias, K | 1 |
| Grigoriou, O | 1 |
| Kouskouni, E | 1 |
| Velegraki, A | 1 |
| Toh, J | 1 |
| Snowball, V | 1 |
| Pastick, KA | 1 |
| Nalintya, E | 1 |
| Tugume, L | 1 |
| Ssebambulidde, K | 1 |
| Stephens, N | 1 |
| Evans, EE | 1 |
| Ndyetukira, JF | 1 |
| Nuwagira, E | 1 |
| Skipper, C | 1 |
| Muzoora, C | 1 |
| Meya, DB | 1 |
| Rhein, J | 1 |
| Boulware, DR | 1 |
| Rajasingham, R | 1 |
| Zhu, Y | 1 |
| Bateman, BT | 1 |
| Gray, KJ | 1 |
| Hernandez-Diaz, S | 1 |
| Mogun, H | 1 |
| Straub, L | 1 |
| Huybrechts, KF | 1 |
| Kusanovic, JP | 1 |
| Romero, R | 1 |
| Martinovic, C | 1 |
| Silva, K | 1 |
| Erez, O | 1 |
| Maymon, E | 1 |
| Díaz, F | 1 |
| Ferrer, F | 1 |
| Valdés, R | 1 |
| Córdova, V | 1 |
| Vargas, P | 1 |
| Nilo, ME | 1 |
| Le Cerf, P | 1 |
| Nakazawa, H | 1 |
| Nishina, S | 1 |
| Senoo, Y | 1 |
| Sakai, H | 1 |
| Ito, T | 1 |
| Kikuchi, K | 1 |
| Ishida, F | 1 |
| Pasternak, B | 2 |
| Wintzell, V | 1 |
| Furu, K | 1 |
| Engeland, A | 1 |
| Neovius, M | 1 |
| Stephansson, O | 1 |
| Bérard, A | 1 |
| Sheehy, O | 1 |
| Zhao, JP | 1 |
| Gorgui, J | 1 |
| Bernatsky, S | 1 |
| de Moura, CS | 1 |
| Abrahamowicz, M | 1 |
| Hernández-Torres, A | 1 |
| García-Vázquez, E | 1 |
| Laso-Ortiz, A | 1 |
| Herrero-Martínez, JA | 1 |
| Gómez-Gómez, J | 1 |
| Ssali, A | 1 |
| Namukwaya, S | 1 |
| Bufumbo, L | 1 |
| Seeley, J | 1 |
| G Lalloo, D | 1 |
| Kamali, A | 1 |
| Parkes-Ratanshi, R | 1 |
| Pilmis, B | 1 |
| Jullien, V | 1 |
| Sobel, J | 1 |
| Lecuit, M | 1 |
| Lortholary, O | 1 |
| Charlier, C | 1 |
| Wade, KC | 1 |
| Monk, HM | 1 |
| Kaplan, YC | 1 |
| Koren, G | 1 |
| Bozzo, P | 1 |
| Howley, MM | 1 |
| Carter, TC | 1 |
| Browne, ML | 1 |
| Romitti, PA | 1 |
| Cunniff, CM | 1 |
| Druschel, CM | 1 |
| Mølgaard-Nielsen, D | 1 |
| Svanström, H | 1 |
| Melbye, M | 1 |
| Hviid, A | 1 |
| Yang, L | 1 |
| Su, MQ | 1 |
| Ma, YY | 1 |
| Xin, YJ | 1 |
| Han, RB | 1 |
| Zhang, R | 1 |
| Wen, J | 1 |
| Hao, XK | 1 |
| Tapia, CV | 1 |
| Hermosilla, G | 1 |
| Fortes, P | 1 |
| Alburquenque, C | 1 |
| Bucarey, S | 1 |
| Salinas, H | 1 |
| Rodas, PI | 1 |
| Díaz, MC | 1 |
| Magne, F | 1 |
| Nakamura, S | 1 |
| Izumikawa, K | 1 |
| Seki, M | 1 |
| Kakeya, H | 1 |
| Yamamoto, Y | 1 |
| Yanagihara, K | 1 |
| Miyazaki, Y | 1 |
| Kohno, S | 1 |
| Mudumbi, SV | 1 |
| Kalkanci, A | 1 |
| Güzel, AB | 1 |
| Khalil, II | 1 |
| Aydin, M | 1 |
| Ilkit, M | 1 |
| Kuştimur, S | 1 |
| Lachhab, L | 1 |
| Rasmouni, K | 1 |
| Ait Ben Haddou, EH | 1 |
| Maamar, M | 1 |
| Seffar, M | 1 |
| Regragui, W | 1 |
| Benomar, A | 1 |
| Yahyaoui, M | 1 |
| Mlinarić Missoni, E | 1 |
| Baršić, B | 1 |
| Bean, LM | 1 |
| Jackson, JR | 1 |
| Dobak, WJ | 1 |
| Beiswenger, TR | 1 |
| Thorp, JA | 1 |
| Stenberg-Nilsen, H | 1 |
| Marinov, B | 1 |
| Petkova, C | 1 |
| Kolarov, G | 1 |
| Georgiev, S | 1 |
| Iunakova, M | 1 |
| Lopez-Rangel, E | 1 |
| Van Allen, MI | 1 |
| Crawford, JT | 1 |
| Pereira, L | 1 |
| Buckmaster, J | 1 |
| Gravett, MG | 1 |
| Tolosa, JE | 1 |
| Annapureddy, SR | 1 |
| Masterson, SW | 1 |
| David, HG | 1 |
| Greig, JR | 1 |
| Benjamin, DK | 1 |
| Nørgaard, M | 1 |
| Pedersen, L | 1 |
| Gislum, M | 1 |
| Erichsen, R | 1 |
| Søgaard, KK | 1 |
| Schønheyder, HC | 1 |
| Sørensen, HT | 1 |
| Krcmery, S | 1 |
| Masar, O | 1 |
| Krcmery, V | 1 |
| Inman, W | 1 |
| Pearce, G | 1 |
| Wilton, L | 1 |
| Pursley, TJ | 1 |
| Blomquist, IK | 1 |
| Abraham, J | 1 |
| Andersen, HF | 1 |
| Bartley, JA | 1 |
| Wray, CM | 1 |
| Baud, O | 1 |
| Boithias, C | 1 |
| Lacaze-Masmonteil, T | 1 |
| Ville, Y | 1 |
| Guibert, M | 1 |
| Zupan, V | 1 |
| Chabernaud, JL | 1 |
| André, P | 1 |
| Nordmann, P | 1 |
| Frydman, R | 1 |
| Dehan, M | 1 |
| Aleck, KA | 1 |
| Bartley, DL | 1 |
| Albukrek, D | 1 |
| Davidson, S | 1 |
| Merlob, P | 1 |
| Busowski, JD | 1 |
| Safdar, A | 1 |
| Paz, A | 1 |
| Gonen, R | 1 |
| Potasman, I | 1 |
| Laufer, B | 1 |
| Bender, HG | 1 |
| Lee, BE | 1 |
| Feinberg, M | 1 |
| Abraham, JJ | 1 |
| Murthy, AR | 1 |
7 reviews available for fluconazole and Complications, Infectious Pregnancy
| Article | Year |
|---|---|
Cryptococcosis in pregnancy and the postpartum period: Case series and systematic review with recommendations for management.
Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Clinical Trials as Topic; Cryptococcus neoform | 2020 |
[Candida sp endocarditis. Experience in a third-level hospital and review of the literature].
Topics: Acute Kidney Injury; Adult; Aged; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Bacteria | 2013 |
Antifungal drugs during pregnancy: an updated review.
Topics: Administration, Intravenous; Administration, Topical; Amphotericin B; Anti-Infective Agents, Local; | 2015 |
New antifungal and antiviral dosing.
Topics: Acyclovir; Amphotericin B; Antifungal Agents; Antiviral Agents; Candidiasis, Invasive; Cytomegalovir | 2015 |
Pulmonary cryptococcosis in late pregnancy and review of published literature.
Topics: Adult; Antifungal Agents; Cryptococcosis; Diagnosis, Differential; Female; Fluconazole; Humans; Lung | 2009 |
[Fluconazole administration during pregnancy].
Topics: Abnormalities, Drug-Induced; Antifungal Agents; Candidiasis; Candidiasis, Vulvovaginal; Female; Fluc | 1998 |
[Current developments in antimycotic therapy in gynecology and obstetrics].
Topics: Animals; Antifungal Agents; Candidiasis, Vulvovaginal; Dose-Response Relationship, Drug; Female; Flu | 1992 |
2 trials available for fluconazole and Complications, Infectious Pregnancy
| Article | Year |
|---|---|
Pregnancy in HIV clinical trials in Sub Saharan Africa: failure of consent or contraception?
Topics: Adult; Africa South of the Sahara; Antifungal Agents; Condoms; Condoms, Female; Contraception; Contr | 2013 |
[Some opportunities for the application of the drug mycosyst (preliminary communication)].
Topics: Adult; Antifungal Agents; Clinical Trials as Topic; Female; Fluconazole; Humans; Middle Aged; Pregna | 2003 |
34 other studies available for fluconazole and Complications, Infectious Pregnancy
| Article | Year |
|---|---|
Fenticonazole activity measured by the methods of the European Committee on Antimicrobial Susceptibility Testing and CLSI against 260 Candida vulvovaginitis isolates from two European regions and annotations on the prevalent genotypes.
Topics: Adult; Antifungal Agents; Candida albicans; Candida glabrata; Candidiasis, Vulvovaginal; Cluster Ana | 2009 |
Postpartum sepsis caused by an intra-abdominal yeast infection.
Topics: Adult; Antifungal Agents; Candida albicans; Candidiasis; Female; Fluconazole; Humans; Postpartum Per | 2020 |
Oral fluconazole use in the first trimester and risk of congenital malformations: population based cohort study.
Topics: Abnormalities, Drug-Induced; Administration, Oral; Adult; Antifungal Agents; Candidiasis, Vulvovagin | 2020 |
Transabdominal collection of amniotic fluid "sludge" and identification of Candida albicans intra-amniotic infection.
Topics: Adult; Amniocentesis; Amniotic Fluid; Antifungal Agents; Candida albicans; Candidiasis; Cervix Uteri | 2018 |
Breakthrough Candida guilliermondii (Meyerozyma guilliermondii) fungemia after cord blood transplantation for extranodal NK-cell lymphoma with azole prophylaxis.
Topics: Adult; Antibiotic Prophylaxis; Antifungal Agents; Candida; Candidemia; Candidiasis, Invasive; Cord B | 2018 |
Oral Fluconazole in Pregnancy and Risk of Stillbirth and Neonatal Death.
Topics: Administration, Oral; Antifungal Agents; Cohort Studies; Female; Fluconazole; Humans; Infant, Newbor | 2018 |
Associations between low- and high-dose oral fluconazole and pregnancy outcomes: 3 nested case-control studies.
Topics: Abortion, Spontaneous; Administration, Oral; Adolescent; Adult; Antifungal Agents; Candidiasis, Vulv | 2019 |
Fluconazole exposure during pregnancy.
Topics: Abnormalities, Drug-Induced; Antifungal Agents; Candidiasis, Vulvovaginal; Female; Fluconazole; Huma | 2015 |
Fluconazole use and birth defects in the National Birth Defects Prevention Study.
Topics: Abnormalities, Drug-Induced; Adult; Antifungal Agents; Candidiasis; Case-Control Studies; Female; Fl | 2016 |
Association Between Use of Oral Fluconazole During Pregnancy and Risk of Spontaneous Abortion and Stillbirth.
Topics: Abortion, Spontaneous; Administration, Oral; Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Ca | 2016 |
Epidemiology, species distribution, antifungal susceptibility, and ERG11 mutations of Candida species isolated from pregnant Chinese Han women.
Topics: Adult; Antifungal Agents; Candida; Candidiasis; Cytochrome P-450 Enzyme System; Drug Resistance, Fun | 2016 |
Genotyping and Persistence of Candida albicans from Pregnant Women with Vulvovaginal Candidiasis.
Topics: Administration, Topical; Adolescent; Adult; Antifungal Agents; Candida albicans; Candidiasis, Vulvov | 2017 |
Disseminated cryptococcosis in an HIV-negative pregnancy: a case of cryptococcal septic abortion complicating an immunocompetent pregnancy.
Topics: Abortion, Septic; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Female; Fluconazole; H | 2010 |
Yeast vaginitis during pregnancy: susceptibility testing of 13 antifungal drugs and boric acid and the detection of four virulence factors.
Topics: Adolescent; Adult; Amphotericin B; Animals; Antifungal Agents; Boric Acids; Candida albicans; Candid | 2012 |
Fluconazole: teratogenicity.
Topics: Adult; Antifungal Agents; Female; Fluconazole; Humans; Pregnancy; Pregnancy Complications, Infectiou | 2012 |
Cryptococcosis in an immunocompetent pregnant woman.
Topics: Adult; Amphotericin B; Antifungal Agents; Apgar Score; Brain; Cryptococcosis; Female; Fluconazole; H | 2013 |
[The Polish Gynecological Society Expert Committee recomendations regarding application of fluconazole in the treatment of vulvovaginal candidiasis].
Topics: Acute Disease; Administration, Topical; Antifungal Agents; Candida; Candidiasis, Vulvovaginal; Chron | 2012 |
Two rare cases of central nervous system opportunistic mycoses.
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillus nidulans; Cryptococcus neoformans; Female; Flu | 2012 |
Intra-amniotic fluconazole therapy for Candida albicans intra-amniotic infection.
Topics: Abruptio Placentae; Adult; Amnion; Anti-Bacterial Agents; Antifungal Agents; Candidiasis; Cesarean S | 2013 |
[Use of fluconazole during pregnancy].
Topics: Antifungal Agents; Candidiasis, Vulvovaginal; Dose-Response Relationship, Drug; Female; Fluconazole; | 2003 |
Prenatal exposure to fluconazole: an identifiable dysmorphic phenotype.
Topics: Abnormalities, Drug-Induced; Abnormalities, Multiple; Antifungal Agents; Female; Fluconazole; HIV In | 2005 |
Amniocentesis results and novel proteomic analysis in a case of occult candidal chorioamnionitis.
Topics: Adult; Amniocentesis; Antifungal Agents; Candidiasis; Chorioamnionitis; Female; Fluconazole; Humans; | 2006 |
Post partum osteomyelitis due to Cryptococcus neoformans.
Topics: Adult; Antifungal Agents; Cryptococcosis; Debridement; Female; Fluconazole; Humans; Injections, Intr | 2007 |
First, do no harm.
Topics: Antifungal Agents; Candidiasis; Developmental Disabilities; Female; Fluconazole; Humans; Incidence; | 2008 |
Maternal use of fluconazole and risk of congenital malformations: a Danish population-based cohort study.
Topics: Abnormalities, Drug-Induced; Antifungal Agents; Candidiasis; Cohort Studies; Denmark; Female; Flucon | 2008 |
Nosocomial Torulopsis glabrata fungemia with shock in a pregnant woman successfully treated with high doses of fluconazole and delivery of healthy child.
Topics: Adult; Candida; Cross Infection; Female; Fluconazole; Fungemia; Humans; Infant, Newborn; Pregnancy; | 1995 |
Safety of fluconazole in the treatment of vaginal candidiasis. A prescription-event monitoring study, with special reference to the outcome of pregnancy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Candidiasis, Vulvovaginal; Child; Child, Preschool; Drug | 1994 |
Fluconazole-induced congenital anomalies in three infants.
Topics: Abnormalities, Drug-Induced; Adult; Antifungal Agents; Bone and Bones; Coccidioidomycosis; Face; Fem | 1996 |
Congenital anomalies and fluconazole.
Topics: Abnormalities, Drug-Induced; Abnormalities, Multiple; Animals; Antifungal Agents; Candidiasis, Vulvo | 1997 |
[Maternofetal disseminated candidiasis and high-grade prematurity].
Topics: Adult; Amphotericin B; Antifungal Agents; Candidiasis; Female; Fluconazole; Humans; Infant, Newborn; | 1997 |
Multiple malformation syndrome following fluconazole use in pregnancy: report of an additional patient.
Topics: Abnormalities, Multiple; Adult; Amphotericin B; Antifungal Agents; Coccidioides; Coccidioidomycosis; | 1997 |
Treatment for coccidioidomycosis in pregnancy?
Topics: Amphotericin B; Antifungal Agents; Coccidioidomycosis; Erythema Nodosum; Female; Fluconazole; Humans | 2001 |
Candida sepsis following transcervical chorionic villi sampling.
Topics: Adult; Antifungal Agents; Candida albicans; Candidiasis; Chorionic Villi Sampling; Diagnosis, Differ | 2001 |
Congenital malformations in an infant born to a woman treated with fluconazole.
Topics: Abnormalities, Drug-Induced; Coccidioidomycosis; Congenital Abnormalities; Female; Fluconazole; Huma | 1992 |